[1]
M. T. Mouritzen, “Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study”, AO, vol. 61, no. 4, pp. 409–416, Apr. 2022.